Evidence map›Paper›PMID 40291837›Full record

ReviewFrontiers in ophthalmology2025

Management of vision loss associated with complications of cosmetic filler injections.

Samantha Madala, Shaili Davuluru, Joy Li, Jeffrey Gluckstein, John Martin, Kasra Khatibi, Sandy Zhang-Nunes

Abstract readReview
In one paragraph

Review in Frontiers in ophthalmology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Samantha MadalaUniversity of Southern California (USC) Roski Eye Institute, Keck School of Medicine of the University of Southern California, Los Angeles, CA, United States.
Shaili DavuluruUniversity of Southern California (USC) Roski Eye Institute, Keck School of Medicine of the University of Southern California, Los Angeles, CA, United States.
Joy LiUniversity of Southern California (USC) Roski Eye Institute, Keck School of Medicine of the University of Southern California, Los Angeles, CA, United States.
Jeffrey GlucksteinUniversity of Southern California (USC) Roski Eye Institute, Keck School of Medicine of the University of Southern California, Los Angeles, CA, United States.
John MartinIndependent Practitioner, Coral Gables, FL, United States.
Kasra KhatibiUniversity of Southern California (USC) Roski Eye Institute, Keck School of Medicine of the University of Southern California, Los Angeles, CA, United States.
Sandy Zhang-NunesUniversity of Southern California (USC) Roski Eye Institute, Keck School of Medicine of the University of Southern California, Los Angeles, CA, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Injectable cosmetic fillers have dramatically risen in popularity in recent years. However, as the use of such fillers has become more common, there have been many reports of vision loss secondary to misplaced filler embolizing to the ophthalmic artery resulting in ocular ischemia. Currently, there are no randomized control trials or widely validated clinical guidelines that dictate how injectors should manage ischemic complications of filler embolism. This review aims to explain the possible mechanisms by which a cosmetic filler embolus can occlude the ophthalmic artery, describe the types of treatments that have been attempted thus far, and delineate possible a stroke-like protocol that can be implemented in order to restore perfusion and recover vision after such ischemic complications have occurred.

Indexed as

cosmetic fillersfiller complicationsinjectable fillersocular ischemiaorbital ischemia

Identifiers

PMID40291837
PMCPMC12021870

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.